HGC019 is a mRNA and Self-amplifying mRNA (saRNA) based COVID-19 vaccine candidate being developed by Gennova Biopharmaceuticals and HDT Bio Corp. with...
6 KB (362 words) - 16:05, 7 October 2023
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)...
337 KB (26,345 words) - 23:53, 10 September 2024
Inactivated KD-414 NDV-HXP-S RNA ARCT-021 ARCT-154 Bangavax CureVac (terminated) HGC019 mRNA-1283 PTX-COVID19-B Sanofi–Translate Bio (terminated) Stemirna COVID-19...
180 KB (23,898 words) - 14:59, 19 August 2024
Capacity BBV154 Adenovirus vector (intranasal) Completed In progress Pending 175 100 million HGC019 mRNA Completed In progress Pending 120 60 million...
181 KB (11,351 words) - 23:42, 5 August 2024
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)...
13 KB (1,240 words) - 06:09, 12 August 2024
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)...
7 KB (260 words) - 15:20, 22 April 2023
Press Information Bureau. Retrieved 13 January 2021. "mRNA Vaccines – HGC019". Gennova Biopharmaceuticals Limited. Retrieved 13 January 2021. "Safety...
95 KB (18,965 words) - 23:35, 15 September 2024
(Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)...
6 KB (371 words) - 05:00, 23 March 2023